ArticleActa pharmaceutica Sinica. B2022

Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212].

Yunhao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.